Publications by authors named "Alpaslan Erkan"

Claim this Profile
N
New risk factors in determining long‑term mortality in patients undergoing TAVI: can the conventional risk scores be used as a long‑term mortality predictor?
Erkan Alpaslan, Huseyin Dursun, Zulkif Tanriverdi, Tugce Colluoglu, Dayimi Kaya

Kardiol Pol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome.
Edem Efe, Ibrahim Kocayiğit, Pabuccu Mustafa Türker, Küçükukur Murat, Alpaslan Erkan

Indian J Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does "smoker's paradox" exist in clopidogrel-treated Turkish patients with acute coronary syndrome.
Efe Edem, Ali Hikmet Kirdök, Ahmet Ozan Kınay, Ümit İlker Tekin, Sedat Taş, Erkan Alpaslan

Platelets· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Severe Tricuspid Regurgitation on Accuracy of Echocardiographic Pulmonary Artery Systolic Pressure Estimation.
Ebru Özpelit, Bahri Akdeniz, Emre Mehmet Özpelit, Sedat Tas, Erkan Alpaslan

Echocardiography· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis